QDENGA Dengue Vaccine: Eligibility, Doses and Safety

What is QDENGA?

QDENGA is designed to reduce dengue disease. It does not treat an active dengue infection. Because it is a live-attenuated vaccine, specific safety restrictions apply. Vaccination should occur through an authorised service after an appropriate eligibility assessment and according to current official guidance.

WHO recommends programmatic use of QDENGA for children aged 6–16 years in settings with high dengue transmission intensity. This public-health recommendation is not identical to every country’s product licence. Local regulatory conditions and national or state vaccination policy must be checked separately.

How many doses are required?

The standard schedule consists of two subcutaneous injections three months apart. Protection should not be assumed immediately after the first dose, and completing a course does not provide 100% protection. If a dose is delayed, ask the vaccination provider how to continue; do not restart or alter the schedule without advice.

Who needs particular caution?

• People with weakened immunity due to disease or immune-suppressing treatment
• Pregnant or breastfeeding individuals
• Anyone with a severe allergic reaction to a previous dose or vaccine component
• People currently unwell with significant fever
• Those taking medicines that affect immunity

Eligibility must be assessed individually. Do not use another country’s age range or an online advertisement as a personal prescription.

Possible side effects

Commonly reported reactions include injection-site pain or redness, headache, muscle pain, weakness, feeling unwell and sometimes fever. These are often short-lived, but serious allergic reactions can occur rarely. Vaccination should take place where immediate assessment and treatment of anaphylaxis are available.

Seek urgent care for breathing difficulty, facial or throat swelling, widespread hives, fainting or rapidly worsening symptoms after vaccination.

Mosquito protection remains essential

No dengue vaccine offers complete protection. Use repellents according to instructions, wear covering clothing, use screens or nets where appropriate and remove standing water around homes. Aedes mosquitoes often bite during the daytime. Community mosquito control protects vaccinated and unvaccinated people.

Approval, availability and eligibility are different

A marketing authorisation permits a product under specified conditions. It does not guarantee immediate supply at every hospital or pharmacy. Distribution, authorised vaccination sites, pricing, government policy and stock may change. Individual eligibility is a separate medical decision.

Patients in Krishnanagar, Nikol, Naroda, Nava Naroda, Odhav, Vastral and East Ahmedabad should verify current official information and availability before travelling. Lotus Hospital does not claim routine QDENGA availability through this article.